最近在临床前开发的阿迪波涅克受体对杜申肌肉发育不良的激素治疗方法的进展
Shivam Gandhi1, Gary Sweeney2, Christopher G R Perry1
1School of Kinesiology and Health Science, Muscle Health Research Centre, York University, Toronto, ON M3J 1P3, Canada.
Biomedicines
|July 27, 2024
概括
阿迪波涅克丁受体激动剂通过减少炎症和纤维化来治疗杜申肌肉发育不良 (DMD) 是有前途的. 需要进一步的研究来了解它们的机制,并支持对这种遗传性肌肉消耗疾病的临床试验.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 杜氏肌肉发育不良 (DMD) 源于双基因突变,导致肌肉纤维损伤,炎症和纤维化.
- 目前用于DMD的类固醇治疗具有显著的副作用,突出显示出需要新的治疗策略.
- 阿迪波尼克丁受体 (AdipoR) 激动剂由于其抗炎,抗纤维和亲肌原作用,可以提供潜在的治疗益处.
研究的目的:
- 探索阿迪波涅克丁信号传导在改善DMD病理方面的治疗潜力.
- 调查在DMD中阿迪波R激动剂疗效背后的机制,包括炎症和非炎症途径.
- 评估目前的证据支持阿迪波R激动剂的进展到DMD的临床试验.
主要方法:
- 对人类和动物DMD模型的临床前研究的综述.
- 对AdipoR激动剂对肌肉细胞和组织的影响数据的分析.
- 检查由adiponectin调节的炎症和非炎症信号通路.
主要成果:
- 在DMD模型中,AdipoR激动剂表现出抗炎,抗纤维和亲肌原性质.
- 有证据表明,阿迪波涅克信号传递可以抵消消毒素缺乏的关键病理特征.
- 有限的DMD特异性数据和对机制的不完全理解需要进一步研究.
结论:
- 阿迪波涅克丁受体激动剂代表了杜申尼肌肉发育不良的有希望的治疗途径.
- 进一步的研究至关重要,以阐明精确的机制,并验证AdipoR激动剂在DMD的临床应用.
- 目前的数据保证了未来的DMD临床试验对AdipoR激动剂的继续调查.
更多相关视频
相关概念视频
01:24Glucagon-like Receptor Agonists
312
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
312
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K